Mental Health Clinics in Riegelwood, NC Accepting Medicare
3 Mental Health Clinics found. Showing 1 - 3
 Acg Community Services Llc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 1394 E Arcadia Rd, Riegelwood, NC 28456 Phone: 910-398-4790 |
The Center For Alternative Resources And Education Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 1183 East Arcadia Road, Riegelwood, NC 28456 Phone: 919-460-8522 Fax: 919-460-8502 |
Counseling Wellness & Health, Llc Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 671 Dickson Rd, Riegelwood, NC 28456 Phone: 910-620-6998 |
News Archive
Deadline for getting coverage and avoiding fines - Valentine's Day, not march 31
The Associated Press reports on this development - which it called a "new wrinkle" - that will move up by about six weeks the date by which consumers will need to have health insurance or face penalties. Also in the news, lots of talk - some of which came from President Barack Obama himself - about how the health law helps or hurts workers and how it impacts health care costs.
NIPH study finds NDMA as one of the most carcinogenic compounds formed during CO2 capture
CO2 capture by means of amines is considered to be the most appropriate method to quickly begin with CO2 removal. During this capture process, some of the amines escaping the recycling process will be emitted into the air and will also form other compounds such as nitrosamines and nitramines.
Researchers find medication for diabetes, smoking cessation
The script for two research teams inducted today into the American Chemical Society (ACS) scientific "hall of fame" the ACS Heroes of Chemistry is a tale of two pills. One team invented a medication that helps people with diabetes control their blood sugar levels. The second team invented a medicine that helps people stop smoking, an addiction that experts regard as today's single greatest preventable cause of death worldwide.
Arsanis closes Series A financing for $10 million
Arsanis, Inc, a recently founded biotechnology company dedicated to the development of anti-infective monoclonal antibody therapeutics, today announced the closing of a Series A financing with a total funding amount of $10 million. Proceeds from the initial financing will be used to advance several programs in the anti-microbial infectious disease area.
Enzalutamide shows promise in treating triple-negative and estrogen-positive breast cancer
Breast cancers are defined by their drivers - estrogen and progesterone receptors (ER and PR) and HER2 are the most common, and there are drugs targeting each. When breast cancer has an unknown driver, it also has fewer treatment options - this aggressive form of breast cancer without ER, PR or HER2, which was thought not to be driven by hormones, is known as triple negative.
› Verified 3 days ago